Abstract
The heterologous expression of proteins is without doubt one of the most fascinating applications of the recombinant DNA technique. Despite clear successes many attempts to produce a certain protein in a heterologous host cell have met with technical difficulties. Secretion from cells has been used as a solution to overcome the intracellular formation of inactive protein. Microorganisms with a history of use in the fermentation industry exhibit clear advantages over the frequently usedEscherichia coli as host cells for secreted products. Interleukin-3, chymosin and phytase are examples of commercial products that are produced efficiently with the aid of industrial microorganisms.
Similar content being viewed by others
References
van den Berg J.A., van der Laken K.J., van Ooyen A.J.J., Renniers T.C.H.M., Rietveld K., Schaap A.:Kluyveromyces as a host for heterologous gene expression: expression and secretion of prochymosin.Bio/Technology 8, 135–139 (1990).
Danley D.E., Geoghegan K.F.: Structure and mechanism of formation of recombinant-derived chymosin C.J.Biol.Chem. 263, 9785–9789 (1988).
van Gorcom R.F.M., van Hartingsveld W., van Paridon P., Veenstra A.C., Luiten R.G.M., Selten G.C.M.: Cloning and expression of microbial phytase.PCT Pat. Appl. WO 9105053 (1991).
Howson S.J., Davis R.P.: Production of phytate-hydrolysing enzyme by some fungi.Enzyme Microb.Technol. 5, 377–382 (1983).
Johnson I.S.: Human insulin from recombinant DNA technology.Science 219, 632–637 (1983).
Jongbloed W.W., Mroz Z., Kemme P.A.: The effect of supplementaryAspergillus phytase in diets for pigs.J.Anim.Sci. 70, 1159–1168 (1992).
Kricek F., Ruf C., Aschauer H., Stuchlik P., Graf C., Seifert J.M.: Hybrid genes expressing fusion peptides. A strategy for bacterial production of recombinant human interleukin-3 with a defined NH2-terminus.Ann.New York Acad.Sci. 646, 136–139 (1991).
van Leen R.W., Bakhuis J.G., van Beckhoven R.F.W.C., Burger H., Dorssers L.C.J., Hommes R.W.J.: Production of human interleukin-3 using industrial microorganisms.Bio/Technology 9, 47–52 (1991).
Postmus P.E., Gietema A.A., Damsma O., Biesma B., Limburg P.C., Vellenga E., de Vries E.G.E.: Effects of recombinant human interleukin-3 in patients with relapsed small-cell lung cancer treated with chemotherapy: a dose-finding study.J.Clin.Oncol. 10, 1131–1140 (1992).
Quax W.J., Bonekamp A.J., van Tilborg M.: Correct secretion of heterologous proteins fromBacillus licheniformis, pp. 143–150 inIndustrial Microorganisms: Basic and Applied Molecular Genetics (Baltz, Hegeman, Skatrud, Eds). Amer. Soc. Microbiol., Washington (DC) 1993.
Ward M., Wilson L.J., Kodama K.H., Rey M.W., Berka R.M.: Improved production of chymosin inAspergillus by expression as a glucoamylase-chymosin fusion.Bio/Technology 8, 435–440 (1990).
Author information
Authors and Affiliations
Additional information
Part of this study was conducted with sponsoring from theEU Commission (project CT9302540).
Rights and permissions
About this article
Cite this article
Quax, W.J. Merits of secretion of heterologous proteins from industrial microorganisms. Folia Microbiol 42, 99–103 (1997). https://doi.org/10.1007/BF02898715
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02898715